[EN] UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS, THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASES CAUSED BY SUCH MUTATIONS [FR] COMPOSES D'ACIDE BENZOIQUE A SUBSTITUTION UREIDO ET LEUR UTILISATION POUR LA SUPPRESSION DE NON-SENS ET LE TRAITEMENT DE MALADIE
[EN] UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS, THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASES CAUSED BY SUCH MUTATIONS [FR] COMPOSES D'ACIDE BENZOIQUE A SUBSTITUTION UREIDO ET LEUR UTILISATION POUR LA SUPPRESSION DE NON-SENS ET LE TRAITEMENT DE MALADIE
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
申请人:Wilde G. Richard
公开号:US20060167065A1
公开(公告)日:2006-07-27
The invention encompasses ureido substituted benzoic acid compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions.
Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides
作者:A. Chris Krueger、Darold L. Madigan、Wen W. Jiang、Warren M. Kati、Dachun Liu、Yaya Liu、Clarence J. Maring、Sherie Masse、Keith F. McDaniel、Tim Middleton、Hongmei Mo、Akhteruzzaman Molla、Debra Montgomery、John K. Pratt、Todd W. Rockway、Rong Zhang、Dale J. Kempf
DOI:10.1016/j.bmcl.2006.04.015
日期:2006.7
Substituted N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides were investigated as inhibitors of genotype I HCV polymerase. Structure-activity relationship patterns for this class of compounds are discussed. (c) 2006 Elsevier Ltd. All rights reserved.
[EN] UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS, THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASES CAUSED BY SUCH MUTATIONS<br/>[FR] COMPOSES D'ACIDE BENZOIQUE A SUBSTITUTION UREIDO ET LEUR UTILISATION POUR LA SUPPRESSION DE NON-SENS ET LE TRAITEMENT DE MALADIE